{
  "title": "Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC",
  "url": "https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% completed assessments, reducing discontinuation risk by 30%"
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Automate reminders at day 3 to improve ePRO completion rates"
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA requiring PRO data in trials within 12 months"
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Baseline differences across studies may affect comparability of PRO outcomes"
    }
  ],
  "model": "granite4:tiny-h"
}